Literature DB >> 22911253

A CRP genetic polymorphism associated with the tumoral expression of CRP in esophageal cancer.

Satoru Motoyama1, Toshinobu Nakatsu, Masatomo Miura, Yudai Hinai, Yoshihiro Minamiya, Jun-ichi Ogawa.   

Abstract

C-reactive protein (CRP) produced locally within esophageal cancer is associated with the prognosis and the rate of recurrence. CRP genetic polymorphisms reportedly affect serum CRP concentrations; however, there are no reports of an association between genetic polymorphisms and tumoral CRP expression. This study enrolled 73 Japanese patients classified with Stage IIA-IV thoracic esophageal squamous cell cancer, and also investigated their CRP genetic polymorphisms using DNA extracted from their peripheral blood. The study then assessed the association between CRP genetic polymorphisms and tumoral CRP expression. The results revealed a significant association between the CRP 1846C>T genetic polymorphism and tumoral CRP expression. This finding suggests that tumoral CRP production controlled by CRP genetics significantly influences tumor behavior.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22911253     DOI: 10.1007/s00595-012-0294-6

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  6 in total

1.  Single-nucleotide polymorphisms in the C-reactive protein (CRP) gene promoter that affect transcription factor binding, alter transcriptional activity, and associate with differences in baseline serum CRP level.

Authors:  A J Szalai; J Wu; E M Lange; M A McCrory; C D Langefeld; A Williams; S O Zakharkin; V George; D B Allison; G S Cooper; F Xie; Z Fan; J C Edberg; R P Kimberly
Journal:  J Mol Med (Berl)       Date:  2005-03-19       Impact factor: 4.599

2.  Polymorphisms within the C-reactive protein (CRP) promoter region are associated with plasma CRP levels.

Authors:  Christopher S Carlson; Shelley Force Aldred; Philip K Lee; Russell P Tracy; Stephen M Schwartz; Mark Rieder; Kiang Liu; O Dale Williams; Carlos Iribarren; E Cora Lewis; Myriam Fornage; Eric Boerwinkle; Myron Gross; Cashell Jaquish; Deborah A Nickerson; Richard M Myers; David S Siscovick; Alexander P Reiner
Journal:  Am J Hum Genet       Date:  2005-05-16       Impact factor: 11.025

3.  Expression of C-reactive protein by renal cell carcinomas and unaffected surrounding renal tissue.

Authors:  Wolfram J Jabs; Marleen Busse; Stefan Krüger; Dieter Jocham; Jürgen Steinhoff; Christian Doehn
Journal:  Kidney Int       Date:  2005-11       Impact factor: 10.612

4.  Tumoral CRP expression in thoracic esophageal squamous cell cancers is associated with poor outcomes.

Authors:  Toshinobu Nakatsu; Satoru Motoyama; Kiyotomi Maruyama; Shuetsu Usami; Yusuke Sato; Masatomo Miura; Yudai Hinai; Hajime Saito; Yoshihiro Minamiya; Katsuyuki Murata; Jun-ichi Ogawa
Journal:  Surg Today       Date:  2012-02-21       Impact factor: 2.549

Review 5.  C-reactive Protein.

Authors:  Steven Black; Irving Kushner; David Samols
Journal:  J Biol Chem       Date:  2004-08-26       Impact factor: 5.157

6.  Immunohistochemical expression of C-reactive protein in squamous cell carcinoma of the esophagus - significance as a tumor marker.

Authors:  Tadahiro Nozoe; Daisuke Korenaga; Motonori Futatsugi; Hiroshi Saeki; Yoshihiko Maehara; Keizo Sugimachi
Journal:  Cancer Lett       Date:  2003-03-20       Impact factor: 8.679

  6 in total
  6 in total

1.  C-reactive protein genetic polymorphisms increase susceptibility to HBV-related hepatocellular carcinoma in a Chinese population.

Authors:  Qiliu Peng; Shan Ren; Xianjun Lao; Yu Lu; Xiaolian Zhang; Zhiping Chen; Xue Qin; Shan Li
Journal:  Tumour Biol       Date:  2014-07-16

2.  Do preoperative serum C-reactive protein levels predict the definitive pathological stage in patients with clinically localized prostate cancer?

Authors:  Thomas J Schnoeller; Julie Steinestel; Konrad Steinestel; Florian Jentzmik; Andres J Schrader
Journal:  Int Urol Nephrol       Date:  2015-03-19       Impact factor: 2.370

3.  Genetic polymorphisms of C-reactive protein increase susceptibility to HBV-related hepatocellular carcinoma in a Guangxi male population.

Authors:  Xianjun Lao; Shan Ren; Yu Lu; Dongmei Yang; Xue Qin; Shan Li
Journal:  Int J Clin Exp Pathol       Date:  2015-12-01

4.  Development of a new outcome prediction model for Chinese patients with penile squamous cell carcinoma based on preoperative serum C-reactive protein, body mass index, and standard pathological risk factors: the TNCB score group system.

Authors:  Zai-Shang Li; Peng Chen; Kai Yao; Bin Wang; Jing Li; Qi-Wu Mi; Xiao-Feng Chen; Qi Zhao; Yong-Hong Li; Jie-Ping Chen; Chuang-Zhong Deng; Yun-Lin Ye; Ming-Zhu Zhong; Zhuo-Wei Liu; Zi-Ke Qin; Xiang-Tian Lin; Wei-Cong Liang; Hui Han; Fang-Jian Zhou
Journal:  Oncotarget       Date:  2016-04-12

5.  High CRP values predict poor survival in patients with penile cancer.

Authors:  Sandra Steffens; Andreas Al Ghazal; Julie Steinestel; Rieke Lehmann; Gerd Wegener; Thomas J Schnoeller; Marcus V Cronauer; Florian Jentzmik; Mark Schrader; Markus A Kuczyk; Andres J Schrader
Journal:  BMC Cancer       Date:  2013-05-03       Impact factor: 4.430

6.  Elevated C-reactive protein values predict nodal metastasis in patients with penile cancer.

Authors:  Andreas Al Ghazal; Sandra Steffens; Julie Steinestel; Rieke Lehmann; Thomas J Schnoeller; Anna Schulte-Hostede; Gerd Wegener; Florian Jentzmik; Mark Schrader; Markus A Kuczyk; Andres J Schrader
Journal:  BMC Urol       Date:  2013-10-22       Impact factor: 2.264

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.